Zimbabweans Turn to Cheaper Herbal Remedies as AIDS Drug Costs Soar
September 21, 2007
As Zimbabwe's out-of-control inflation drives up the price of necessities, some patients unable to afford HIV treatment are abandoning antiretrovirals in favor of the traditional Gundamiti herb. The cost of a month's worth of triple-combination ARV treatment has soared from $12 million (US $400) two months ago to $25 million (US $833) today, while Gundamiti costs $2 million (US $66). Some patients taking the herb report their CD4 cell counts have increased; doctors, however, are skeptical.
Voice of America News
09.17.2007; Carole Gombakomba
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.